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Abstract 
The last decades saw dramatic progress in brain research. These advances were often 
buttressed by probing single variables to make circumscribed discoveries, typically through null 
hypothesis significance testing. New ways for generating massive data fueled tension between the 
traditional methodology, used to infer statistically relevant effects in carefully-chosen variables, 
and pattern-learning algorithms, used to identify predictive signatures by searching through 
abundant information. In this article, we detail the antagonistic philosophies behind two 
quantitative approaches: certifying robust effects in understandable variables, and evaluating how 
accurately a built model can forecast future outcomes. We discourage choosing analysis tools via 
categories like ‘statistics’ or ‘machine learning’. Rather, to establish reproducible knowledge about 
the brain, we advocate prioritizing tools in view of the core motivation of each quantitative 
analysis: aiming towards mechanistic insight, or optimizing predictive accuracy. 
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‘[Deep] neural networks are elaborate regression methods aimed solely at prediction, 
not estimation or explanation.’ 
Efron & Hastie [1, p. 371] 
 
The emergence of richer datasets alters everyday data-analysis practices 
There is a burgeoning controversy in neuroscience on what data analysis should be about. 
Similar to many other biomedical disciplines, there are differing perspectives among researchers, 
clinicians, and regulators about the best approaches to make sense of these unprecedented data 
resources. Traditional statistical approaches, such as null hypothesis significance testing, were 
introduced in a time of data scarcity and have been revisited, revised, or even urged to be 
abandoned. Currently, a growing literature advertises predictive pattern-learning algorithms 
hailed to provide some traction on the data deluge [2, 3]. Such modeling tools for prediction are 
increasingly discussed in particular fields of neuroscience [for some excellent sources see: 4, 5-9]. 
Ensuing friction is aggravated by the incongruent historical trajectories of mainstream statistics 
and emerging pattern-learning algorithms – the former long centered on significance testing 
procedures to obtain p-values, the latter with a stronger heritage in computer science [10-12]. We 
argue here that the endeavor of sorting each analysis tool into categories like ‘statistics’ or 
‘machine-learning’ is futile [13, 14]. 
Take for instance ordinary linear regression, as it is routinely applied by many 
neuroscientists. The same tool and its underlying mathematical prosthetics can be used to achieve 
three diverging goals [15, pp. 82-83, 16, ch. 4.12]: a) exploration, to get a first broad impression of 
the dependencies between a set of measured variables in the data at hand, b) inference, to 
discern which particular input variables contribute to the target variable beyond chance level, and 
c) prediction, to enable statements about how well target variables can be guessed based on data 
measured in the future. 
Confusion can arise because it is the motivation for using linear regression that differs 
between these scenarios. The mathematical mechanics underlying model parameter fitting are 
indistinguishable. Taken more broadly, instead of attaching labels of opposing camps to each 
analysis tool, it would be more productive, we would argue, to focus on the desired goal of a 
specific quantitative analysis. The goal, rather than the choice of a particular tool, is the major 
factor that ultimately determines what statements can confidently be made about brains, 
behavior, or genes, or for that matter – any other question of interest. 
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Exploration, inference, prediction: A typology of different modeling goals 
The initial description of a correlative relation in brain data is a common first step in many 
research projects. An important distinction arises when deciding on how to venture into 
identifying reproducible findings in quantitative analysis. How a particular analysis tool is used in a 
certain application domain may often be more important than which class of analysis tool is 
chosen. 
a) Exploration of correlative associations: In various studies, a straightforward approach to 
charting candidate associations in brain data is Pearson’s correlation (without computing p-
values). A simple statistic is thus computed between two series of measurements for 
descriptive purposes. As one concrete example, this analysis can quantify the relationship 
between amygdala activity measured in an fMRI experiment and some behavioral response. 
Such tentative data exploration can also be done in situations involving one input and one 
output variable by fitting a linear regression to the data. In these informal settings, the 
modeling goal is limited to a descriptive, correlational summary of the raw data that one 
happened to observe. Estimating linear-regression parameters alone does not license the 
importance of certain variable relationships (i.e., inference). Neither does a fitted linear 
regression itself declare whether these variable relationships hold up for other individuals or 
future data points (i.e., prediction). 
b) Inference of statistically significant (and possibly causal) associations: Another goal is to try 
to isolate the specific contributions of single variables, to uncover how the observed 
response depends on each particular measurement. This is a common agenda in many well-
controlled experimental designs. For instance, those looking into the effects of gene-
knockout in mice or clinical trials examining the impact of a specific treatment in patients. 
Historically, this type of deductive reasoning has often drawn on null hypothesis significance 
testing (NHST). The framework however is sometimes ill-suited and frequently 
misunderstood [17-19]. As an alternative to NHST, one may draw formal inference by means 
of false discovery rate (FDR), Bayesian posterior inference, or other tools [1, ch. 3 and 15]. 
Inferences also need to take into account various biases [20] to avoid making claims that 
represent false positives (in the NHST framework), underestimated FDR (in the FDR 
framework), or exaggerated posterior parameter distributions (in the Bayesian framework) 
[1, ch. 3, 21, ch. 18.7]. Much debate has emerged about what inferential statements about 
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relevant variable contributions mean [10, 13, 22], and how significant associations tends 
towards the holy grail of uncovering causal influences [23]. 
c) Generalization of predictive associations: One way to substantiate the explored correlations 
or inferred significance statements is by verifying whether these quantitative relationships 
still hold up in other data points or new individuals. This goal common to many 
observational, naturalistic, and prospective epidemiological studies. For instance, 
increasingly, predictive pattern-learning algorithms are used to derive the behavioral 
response of individuals from whole-brain neural activity or derive health risk from genomic 
profiling [cf. 24, 25, 26]. Predictive modeling can also be carried out by standard linear 
regression. Several fields of clinical medicine have already accumulated a large literature of 
predictive scores and tools [27, 28]. Currently, usage of predictive approaches lacks 
standardization and few are rigorously validated [29]. Even fewer are evaluated for 
replication in different settings and groups of individuals [30]. Increasingly complex 
predictive models use hundreds and thousands of parameters and/or try to benefit from 
non-linear interactions in extensive data, like electronic health records [31]. Notably, it has 
so far rarely been shown that accounting for complex non-linearity in “big” medical data has 
considerably improved the predictive performance. The low success rate is perhaps partly 
due to the still insufficient sample sizes or to limited quality of the measurements [7, 20, 32]. 
 
To be clear, exploration, inference, and prediction are not strictly mutually exclusive. Rather, 
quantitative investigations often involve a combination of the three approaches, prioritized to 
different degrees. In many neuroscience domains that are starting to amass “big data” predictive 
pattern-learning algorithms are becoming popular alternatives to classic linear-regression 
applications [2, 3]. Such algorithmic tools include support vector machines, random forests, or 
artificial neural network. Regardless of whether linear-regression approaches or pattern-learning 
algorithms are used, the main goal of the prediction enterprise is to put the built model, with 
already estimated model parameters, to the test in some independent data [21, ch. 7]. In this 
analysis regime, the investigator wishes to achieve the highest-possible forecasting performance. 
She is not necessarily worrying about how the model works or whether its fitted parameters carry 
biological insight.  
 
Inference and prediction serve distinct goals 
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Scientific insight has been a primary focus of the statistical methodology traditionally used 
in fields like psychology, experimental neuroscience, and evidence-based medicine assessments. 
The underlying inferential approach is particularly suited for asking questions such as, ‘Which 
specific gene location contributes to or has an effect on a behavioral trait?’ Somewhat 
counterintuitively, in many cases, genetic variants identified via such an inferential approach may 
not serve best to detect whether somebody has that behavioral trait or not [33, 34]. This is 
because modeling for prediction typically asks a more heuristic type of question, ‘Which gene 
locations are collectively useful to distinguish individuals with or without the behavioral trait?’ 
Finding answers to this latter type of question follows the perhaps more superficial agenda of 
prioritizing successful recognition of any data relationships that are able to derive the specified 
outcome in independent individuals. Such predictive approaches put less emphasis on mechanistic 
insight into the biological underpinnings of the coherent behavioral phenotype (Table 1). 
Inferring new scientific insight is often about answering questions such as ‘which input 
variable within a given dataset is an important contributor to the outcome?’ (or, ‘a relatively 
important contributor, compared to other input variables’?) Ideally, this modeling regime aims at 
mechanistic understanding of the impact of the input on the target variable. The investigator is 
interested in understanding the way in which an outcome y is affected by a change in the input 
variables X1, …, Xp. To put it more mathematically, with X denoting the measurement vector X1, …, 
Xp, she wants to know ‘how y changes as a function of X’ [35, p. 19]. Consequently, inferential data 
analysis becomes hard if the statistical model is a black box. Further, inferential statements about 
individual measurements of brain phenomena have their best chance of being reproducible if 
derived in the context of careful experimental controls (e.g., randomized trials in clinical 
assessments). Importantly, however, many, if not most, questions of interest cannot even be 
addressed using randomization [cf. 1, epilogue]. 
Quantitative analyses that strive to mechanistically explain the inner workings of brain 
phenomena have a different epistemic value than that of research aimed to model brain 
phenomena for the goal of accurate future predictions. In the prediction case, the investigator 
wants to extract knowledge about regularities, by sieving through constellations of candidate 
patterns (and possibly very complicated ones)  [2, 3]. Prediction accuracy is the core metric to 
capture how well the overall quantitative model, that is, the collection of fitted parameters, can 
emulate a high-level abstraction of mechanisms in nature. The predictive approach thus asks, 
‘How well can the built model reproduce the studied brain phenomenon that has been 
quantitatively captured in the measurements?’ 
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The priority to maximize prediction performance may require exploitation of more 
complicated non-linear relationships in brain data, in contrast to widely adopted linear modeling. 
Recognizing complex relationships between variables is something that many black-box pattern-
learning algorithms are particularly good at. The more transparent linear-regression approaches 
have served well in neuroscience and medicine, and are arguably epitomized in the successful era 
of genome-wide association studies (GWAS) [36]. By contrast, the data-led identification of 
predictive principles from non-linear relationships between variables has a strong legacy in the 
machine-learning community [10, 37, ch. 1.2].  
A contrast between modeling goals lies in the readiness of non-linear predictive models to 
capture and capitalize on higher-order interactions among variables. Complex variable-variable(-
variable-...) interactions are probably common in brain phenomena. However, to best “see” these 
higher-order interactions, the data need to be measured with little noise. When adequate data are 
available, more sophisticated analysis tools are generally advantageous in cases of higher-order 
variable interactions. Some non-transparent pattern-learning algorithms, capitalizing on non-
linear interactions, have frequently ranked among the top solutions in international data-analysis 
competitions involving a diversity of challenging data types (e.g., http:/www.kaggle.com). In brain 
research, there is always greater accuracy of measurements and more complete capture of the 
variables that drive higher-order interactions. Thus, advanced pattern-learning algorithms may 
eventually outperform linear models even more often than is currently the case. Importantly, 
though, the superiority of modeling complex patterns over simple linear approaches should not be 
taken for granted, and merits case-by-case evaluation. Altogether, compared to modeling for 
inference, the predictive analyst may favor tools extracting regularities from data in a way that is 
advantageous for prediction accuracy. High forecasting accuracy is favored even if opaque to 
human intuition, with “deep” neural-network algorithms offering an extreme example of such 
tools. 
Besides challenges in parameter interpretation, predictive tools are typically less suited to 
detect causal relationships in data [23]. Nevertheless, a useful predictive model with high accuracy 
may be built based on measurements which are expected to have little causal relation to the 
outcome of interest. For instance, it has been acknowledged that ‘Neuroimaging studies per se [...] 
only provide insights into neural correlates but not into neural causes of cognition’ [38]. 
Neuroimaging measurements such as fMRI are only indirectly related to the dynamic activity 
changes in neuronal assemblies underlying cognitive processes. However, such signals carry 
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intermediate information that can serve for accurate predictions of inter-individual differences in 
cognition such as propensity to attentional lapses, general intelligence, or health status [39, 40]. 
 To recapitulate, we emphasized two types of motivations that could drive a specific 
scientific inquiry: ‘providing insight’, for the purpose of inference, or ‘accurately modeling the 
world’, for prediction. The inferential regime prioritizes statements about the relevance of each 
individual input variables. The predictive regime instead prioritizes the relevance of the model’s 
output for precise forecasting. Predictive modeling describes what ‘does’ happen. Prediction often 
does not equally well address the question of ‘how’, and may be less apt for the question of ‘why’. 
Additionally, prediction is not always feasible and may remain mediocre in certain applications, 
despite recent technical advances in data analytics. These considerations encourage trade-offs 
between model transparency for easy interpretability and model complexity that would enable 
predicting particularly complicated relationships (Figure 1). One could make the case that there 
are some brain phenomena that are so complicated such that impenetrable predictive pattern-
learning algorithms may be all neuroscientists can hope for [cf. 22]. Moreover, accelerating data 
aggregation and wider availability of computation power are opening a ‘shortcut’ path to useful 
outcome predictions, circumventing the traditional milestone of mechanistic discovery as an 
essential step towards effective predictive capabilities.  
 
 
Implications for clinical brain research 
Many clinical studies in brain research set out to identify variables that are statistically 
significantly associated with a disease. This includes significant differences in specific brain 
regions, their neural activity or anatomical abnormality, connections between brain regions, gene 
variants, and more. Deviations in such measurements in patients, however, may not always be 
best-possible choices for building successful predictive approaches [20, 41, p. 185]. This is perhaps 
not too surprising, given that certain questions beg modeling for the inference goal. For instance, 
‘Which particular demographic indicator, ethnic background, or clinical parameter is robustly 
associated with adverse reaction of patients to a drug?’. The context of predictive modeling begs a 
different question at the heart of the study, even when using the same statistical technique. For 
instance, ‘How well can we know in advance the risk of a particular patient for an adverse reaction 
to that drug?’. Predictive modeling regimes, we would argue, provide a natural path towards 
clinical relevance, by immediately acting on clinical endpoints [42]. In fact, an official report of the 
American Statistical Association (ASA) emphasized that ‘Statistical significance is not equivalent to 
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scientific, human, or economic significance. Smaller p-values do not necessarily imply the presence 
of larger or more important effects, and larger p-values do not imply a lack of importance or even 
lack of effect.’ [17]. 
Modeling for inference and prediction are two different tasks. Increasing this awareness 
will probably foster new research directions. Centering on clinical endpoint predictions can 
complement the quest for identifying the biological causes of disease. Historically, in research on 
the neural and genetic basis of brain disease, a prevailing philosophy has been to progress in two 
consecutive steps: discovery of new pathophysiological mechanisms, which are then used as a 
stepping stone to designing new targeted treatments [43]. Yet, one might argue, after >50 years of 
biological research on the brain aimed at inference, there are relatively few definitively 
established etiopathological pathways. Neither are there many reliable biomarkers for most 
mental disorders [44]. 
Even in the ideal case of brain diseases caused by a single gene with considerable 
penetrance, such as in 22q11.2 deletion linked to schizophrenia risk [45] and expansion of CAG 
triplet repeats linked to Huntington’s disease [46], certain clinical endpoints can profit from 
patient-tailored predictive approaches. All individuals with such a genetic variant carry an 
escalated risk of developing the disease. However, various inter-individual differences can still 
arise, including the timing of symptom onset, the constellation of symptoms displayed, disease 
severity, clinical trajectory, and treatment response. These clinical scenarios illustrate the 
distinction between the pursuit of scientific insight and the wish to forecast patient-specific 
disease manifestations – aiming at elucidating disease-causing biological mechanisms or 
prognostic value with relevance for medical care. Without doubt, there potentially are immediate 
gains of the pragmatic intention to search signatures in complex data that can be exploited to 
predict clinical endpoints. Such research program does not conflict with or question the value of 
the longer-term endeavor to understand the primary biology of brain diseases. 
Predictive approaches are increasingly adopted, recommended, and even expected by 
policymakers [47, 48]. However, there are several requirements before they can be considered 
suitable for wide application in real-world clinical settings (Box 1). Beneficial conditions for 
successfully translating new predictive approaches into clinical practice include the following: 
 
i) The input variables for the predictive approach should be unambiguously defined as well as 
measured in a straightforward and standardized way. 
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ii) The prediction performance needs to be better than what can be achieved by already 
existing clinical means for diagnosis and monitoring. 
iii) Accurate predictions need to be carefully validated in diverse settings [49]. It is important to 
accommodate variability that results from contextual factors such as circadian rhythm, 
menstrual cycle, and periods of stress. 
iv) The predictive approach must also show reproducibility in different groups of individuals and 
different ethnicities that did not contribute to model building. In analogy to drug treatments, a 
candidate predictive model can be found, for instance, to work better in males than females or 
be less effective in the elderly. Drug treatments can also have adversary outcomes in 
individuals with specific genetic profiles  [cf. 7]. 
 
v) Predictive successes can only result in better patient management and clinical outcomes if 
effective interventions are available. In Alzheimer’s disease, for instance, a major current effort 
is directed to improving disease prediction years prior to symptom onset. Translating such 
prediction to better clinical outcome, however, would depend on whether treatment 
interventions that can effectively leverage such earlier diagnosis do exist. 
vi) Successful predictive models that are easy-to-use and transparent are likely to be adopted 
more readily by the medical community. Health professionals will probably avoid complex 
modeling approaches that are harder to interpret, require extra training or depend on hard-to-
get information. 
vii) Randomized clinical trials may need to certify the utility of a new predictive approach for 
patients [50, 51]. This important cornerstone of evidence-based medicine will most likely 
continue to bolster clinical guidelines in the “big data” era. 
Finally, we outline various obstacles in the journey towards establishing predictive 
approaches for clinical management and intervention: 
 
i) When using medical data, strong non-linear effects have seldom been explicitly modeled or 
reported [52]. Even if complex interactions exist between measured variables, they may be 
difficult to extract from today’s datasets, particularly those of still limited sample sizes [20]. 
Consequently, simple, less data-hungry predictive approaches are likely to remain among the 
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go-to choices in many clinical settings. Elaborate predictive pattern-learning algorithms often 
cannot yet be used to their full potential, let alone “deep” neural-network algorithms [cf. 53]. 
ii) It is often hard to know the optimal sample size for a particular prediction-oriented clinical 
research program beforehand. This limitation stands in contrast to the availability of power 
calculations in classical statistics. Reasons include the unknown complexity of the aspired 
prediction function, amount of relevant input variables and noise in the data [20, 54, 55, p. 
124]. 
iii) A small signal-to-noise ratio plagues various forms of medical data. Examples of noisy 
measurements include read-outs of histone modifications in genomics and brain activity 
changes scanned using functional MRI, EEG, or MEG. As a rule of thumb, the more complex the 
predictive model, the higher its susceptibility to random variation in the data. Hence, it is 
trickier for advanced pattern-learning algorithms to identify reproducible relations among the 
measured variables. 
iv) Similarly, flexible predictive pattern-learning algorithms with high capacity are more prone 
to overfitting idiosyncrasies in the data [56]. Thus, the various “bells and whistles” of many of 
the sophisticated predictive approaches need to be chosen in a principled fashion [52]. These 
considerations underscore the need for reproducible modeling practices as a core activity in  
brain research [cf. 57]. 
 
v) The lacking transparency of predictive approaches going beyond mainstream linear modeling 
is a particular concern that can erode the trust needed for implementation in clinical practice 
[47, 52]. Indeed, skewed or wrong predictive approaches can systematically inflict harm by 
driving poor decision making [58]. 
 
vi) Because of methodological constraints, much clinical brain research may not directly target 
real-world settings. Rather, clinical studies routinely enroll patients based on stringent 
exclusion criteria, such as medication use or common comorbidities. These study designs may 
impede our ability to make predictions in realistic clinical settings. For instance, assessing the 
effectiveness of drugs or other treatments is particularly hindered when it comes to groups of 
patients that are relatively rarely recruited in clinical studies, such as children and the elderly 
[59]. 
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vii) Electronic health records are soon likely to provide rich resources to build effective 
predictive approaches. Yet, standardized health records involving large samples of patients are 
still scarce. Additionally, a bias towards sicker people has been noted in the few existing studies 
using such patient data provided by medical institutions [30, 60].  
 
 
Concluding remarks and future perspectives 
The advent of “big data” in neuroscience and biomedicine started transforming many 
important sectors. In the 21st century, large-scale data aggregation, catalyzed by new modes of 
data dissemination and open science [61], has reached an unprecedented scale. Yet, it remains 
unclear whether these emerging opportunities also prompt a deeper revision of the traditional 
“value system” pertaining to scientific evidence. The data-rich neuroscientist can ask many new 
questions that could probably never be addressed quantitatively before. We encourage 
investigators and clinicians to re-think data analysis in the context of a repertoire of modeling 
goals (see Outstanding Questions). Choosing a data-analytic strategy for a research question at 
hand should not be a matter of tradition, habit, or taste. 
It is worth reiterating that a specific analysis tool can serve multiple modeling goals. Linear 
regression, for instance, has been often used for exploratory summaries of possible relationships 
among measured variables. The same tool, however, can be used for inferring the most relevant 
mechanistic candidates among the measured variables, as well as predicting outcomes by applying 
the built model to new data points. Conversely, many machine-learning algorithms have a long-
standing track record in serving the predictive goal. Yet, despite the increased complexity of many 
of these algorithmic tools, they can also be partly used towards the aim of data exploration, or 
even inference to isolate individually important input variables. 
More broadly, like any scientific method, modeling for inference or prediction both come 
with certain strengths and weaknesses [19, 34, 62, 63]. Inferential modeling has been an 
established practice for decades [50, 64]. In contrast, the most effective use cases still need to be 
identified for deploying predictive approaches in neuroscience and personalized medicine. 
Ultimately, deducing scientific insights and making pragmatic predictions are intimately related, 
but also differ in important ways. 
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Table 1: The inference-prediction continuum of modeling goals (cf. Figure 1) 
 
 
Inference   <-------------------------------------------------------->   Prediction 
 
Commonly used tools for inference goals: Null 
hypothesis significance testing to compute p-values for 
specific variables. Tools to this end include, for 
example,  ANOVA, t-test, or   -test. Increasingly 
popular alternatives include false discovery rate and 
Bayesian posterior inference, as well as certain pattern-
learning algorithms (e.g., feature importance scores 
from random-forest algorithms) 
Commonly used tools for prediction goals: Validation 
schemes to compute prediction accuracy of the built 
model as a whole. Exemplary tools include support 
vector machines, random-forest algorithms and other 
ensemble and boosting techniques, the rapidly evolving 
“deep” learning algorithms, as well as ordinary and 
penalized linear regression 
Theory-guided: Candidate variables are often hand-
picked by the investigator, in a targeted fashion based 
on existing substantive knowledge. Research questions 
are explicitly articulated before data collection in a 
carefully controlled experiment. The chosen variables 
are evaluated by an often simple, inflexible model that 
ideally, is pre-specified by the investigator before 
seeing the data; but data dredging, and thus high false-
positive rate is common in practice 
Pattern-guided: A large and diverse array of “found” 
variables is typically considered in the statistical analysis 
in a heuristic data-led fashion. It can be unknown how 
the data were generated, and the exact research 
question may be detailed as the data are being 
analyzed. The  adaptive, sometimes very flexible model 
extracts a general prediction rule directly from the data 
themselves 
Explainable narrative: Statements about the specific 
contribution of individual input variables are the 
priority. Such claims of variable relevance are often 
more readily available in simple linear regression 
models. Accordingly, these models tend to be 
preferred in this context, such that every single 
parameter can be cleanly attributed its share of the 
explained variance. Usually, the meaning of each 
parameter should be readily understood and hence the 
model often allows for a simplified narrative; 
statements are centered on single parameters, rather 
than the prediction performance of the collective 
model parameters 
Opaque black box: While simple linear-regression 
models may perform reasonably well in terms of 
predictive power, if the goal is to maximize prediction 
accuracy, it is often beneficial to exploit complicated 
non-additive associations in the data. In many real-
world situations, the target variable depends on the 
input variables in convoluted ways, which can hinder 
assigning to single input variables a clear relative 
contribution to the output; model parameters are often 
treated as instrumental intermediates to achieve high 
prediction performance, without necessarily aiming to 
assign specific meaning to each parameter estimate per 
se 
Formally justified: Many traditional analysis techniques 
were rigorously characterized by mathematical theory; 
simple linear models lend themselves well for 
theoretical model criticism, and carry well-understood 
modeling limits; another benefit is the typically lower 
computational load 
Empirically justified: Predictive models can be explicitly 
and quantitatively evaluated by applying the entire set 
of model parameters to unseen independent, newly 
generated, or future observations or individuals; formal 
performance guarantees are often challenging; these 
models are closely related to more computationally 
demanding cross-validation, bootstrapping, and other 
resampling schemes 
Data-efficient: Many classical statistics methods were 
designed long ago to handle data that are scarce, as 
well as laborious and expensive to collect 
Data-hungry: Compared to classical statistics methods, 
many complicated predictive approaches require more 
data, especially when complex non-linear relationships 
are modeled, and more hyper-parameters need to be 
tuned; comparably more data are also needed if each 
observation tends to have many input variables, and 
random noise is expected to be prominent (e.g., medical 
data) 
Problem-tailored: Each approach is designed to solve a 
particular data-analysis question, typically based on a 
Versatile: Approaches are devised to provide useful 
solutions to various types of data and data-analysis 
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problem-specific probability model of how the data are 
believed to have come about 
questions 
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Box 1: Stages of translating predictive approaches in brain research into practice 
 
1. Model building: To fit the parameters of the chosen predictive model, one first needs empirical 
measurements from the brain systems of interest. One common preparatory analysis is probing 
variable-variable relationships using pairwise correlation plots. Another is estimating genetic 
relatedness between the participants using principal component analysis of the genomic profiles. 
In behavioral experiments in animals or humans, exploratory data summaries can identify 
collinearity in response times. Such collinearity in response times foreshadows hindered 
statements about the relevance of individual experimental conditions (i.e., inference); but hardly 
affects forecasting condition response latencies in new participants (i.e., prediction). 
2. Internal validation: These procedures guard against overly optimistic modeling performances. 
Internal validation procedures, unlike external ones (point 3), do not require new, independent 
data and are based only on the original subject sample or dataset that was used during model 
building [65]. Cross-validation and bootstrapping are resampling methods [21, ch. 7] that can 
estimate metrics of model quality [47], such as expected prediction accuracy on future data, 
uncertainty of parameter estimates, and variability of prediction errors. Indeed, ‘working scientists 
often find the most interesting aspect of the analysis in the lack of fit rather than the fit itself’ [16, 
p. 92]. Yet, inter-individual variability may still be under-appreciated by using these internal 
validations alone [24]. 
3. External validation: For further validation, predictive associations identified from the original 
subject sample or dataset need to be checked in other individuals or in datasets measured later 
[60, 64, 66]. Successful application of a predictive model of disease risk, for instance, requires 
validation in different groups of individuals [24, 29]. This step is important to combat 
reproducibility issues [67]. Currently, such model validations are not done as often as they should 
be [68]. It is however important to comprehensively benchmark the value of each predictive 
approach for clinicians, policy makers, and clinical guidelines [69]. For instance, external validation 
may be performed in different geographical areas, time periods, and settings (e.g., secondary vs. 
primary care). Generally, some authors proposed that ‘the most stringent external validation 
involves testing a final model developed in one country or setting on subjects in another country 
or setting at another time. This validation would test whether the data collection instrument was 
translated into another language properly, whether cultural differences make earlier findings 
nonapplicable, and whether secular trends have changed associations or base rates’ [16, ch. 
5.3.1]. 
 
4. Generalizability and transposability: When testing the predictions of a model on new 
individuals, the more different these individuals are from the original subject sample, the stronger 
the test for generalizability [59, 65]. Prediction accuracies are typically lower than in preceding 
steps. For instance, our ability to predict the clinical utility of drugs tends to be particularly 
hindered for certain groups of patients, including women, children, the elderly. Common 
comorbidities are also frequently underrepresented or excluded in clinical studies. Meta-analysis 
methods can be useful for summarizing and examining a model’s predictive performance across 
different scenarios. Large datasets from multiple studies and electronic health records or registry 
databases provide promising opportunities for examining the generalizability of predictive 
approaches [70]. 
To enhance reproducibility, accurate and complete reporting in studies applying predictive models 
is imperative. Such reporting is crucial for being able to critically appraise predictive models; to 
perform acid-test validations of them; to evaluate their impact; and ultimately, to translate them 
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into clinical practice [27, 71]. 
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Figure Legends 
 
Figure 1: The trade-off between model transparency, which allows for scientific understanding, 
and theoretical model capacity, which affords sophisticated predictions 
Neuroscience and biomedicine had a long-dominating focus on scientific insight using simple and 
thus transparent models. Such approaches are well suited to work towards the goal of inference 
on mechanistic understanding. This goal is epistemologically distinct from and sometimes 
practically incompatible with maximizing predictive power. The pragmatic goal of optimizing 
predictive accuracy can exploit large datasets even at the cost of opting for black-box models that 
cannot easily be interrogated. In practice, the actual ratio between transparency and predictability 
depends on the specific analysis tool being used and the particular dataset at hand. Abbreviations: 
GLM: generalized linear models; LASSO (least absolute shrinkage and selection operator): a 
recently introduced constrained regression for high-dimensional data analysis, which is a special 
instance of GLM. 
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